Sandostatin Lar 20 mg powder and solvent for suspension for injection
Country: Bulgaria
Language: Bulgarian
Source: Изпълнителна агенция по лекарствата
Patient Information leaflet
(PIL)
15-01-2024
Summary of Product characteristics
(SPC)
30-01-2023
Active ingredient:
Октреотид
Available from:
Novartis Pharma GmbH
ATC code:
H01CB2
INN (International Name):
Octreotide
Dosage:
20 mg powder and solvent for suspension for injection
Product summary:
Sandostatin LAR, 20 mg powder and solvent for suspension for injection
Authorization date:
2015-03-11
